KEYS vs SCNI · P/E 57, rev $5.16B vs P/E 0.2, rev $1.3M
Keysight Technologies Inc (KEYS) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the KEYS and SCNI stock pages for the full models.
Not investment advice.